Non-invasive prenatal testing in Germany: a unique ethical and policy landscape
Non-invasive prenatal testing (NIPT) has been available commercially in Europe since approximately 2012. Currently, many countries are in the process of integrating NIPT into their publicly funded healthcare systems to screen for chromosomal aneuploidies such as trisomy 21 (Down syndrome), with a va...
Prif Awduron: | Bowman-Smart, H, Wiesemann, C, Horn, R |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Springer Nature
2022
|
Eitemau Tebyg
-
The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review
gan: Perrot, A, et al.
Cyhoeddwyd: (2021) -
Negotiating severity behind the scenes: prenatal testing in Germany
gan: Nov-Klaiman, T, et al.
Cyhoeddwyd: (2024) -
Non-invasive prenatal testing for ‘non-medical’ traits: ensuring consistency in ethical decision-making
gan: Bowman-Smart, H, et al.
Cyhoeddwyd: (2021) -
Non-Invasive Prenatal Testing in Germany
gan: Thomas Liehr, et al.
Cyhoeddwyd: (2022-11-01) -
Supporting patient decision-making in non-invasive prenatal testing: a comparative study of professional values and practices in England and France
gan: Bowman-Smart, H, et al.
Cyhoeddwyd: (2024)